Metraipolis › archive › dc_7c2d2ccdabe7

Differential musculoskeletal outcome reporting in patients receiving bempedoic acid or atorvastatin: a disproportionality analysis using the EudraVigilance… — Europe PMC PMID:41657777

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41657777
DOI: 10.3389/fphar.2025.1736657
License (as archived): solo-consultazione
Archived: 2026-11-06T13:44:20.321Z
SHA-256 of the archived text: 15152275eabacec7847748bf6956026f466344dfbcf6d650183d541879ca5370
Stable URL of this page: https://metraipolis.com/documento/dc_7c2d2ccdabe7

How to cite

Differential musculoskeletal outcome reporting in patients receiving bempedoic acid or atorvastatin: a disproportionality analysis using the EudraVigilance… — Europe PMC PMID:41657777 — Europe PMC (en), https://europepmc.org/article/MED/41657777 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7c2d2ccdabe7 (Metraipolis archive dc_7c2d2ccdabe7, sha256 15152275eabacec7847748bf6956026f466344dfbcf6d650183d541879ca5370)

BibTeX

@misc{dc7c2d2ccdabe7,
  title = {Differential musculoskeletal outcome reporting in patients receiving bempedoic acid or atorvastatin: a disproportionality analysis using the EudraVigilance… — Europe PMC PMID:41657777},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41657777},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7c2d2ccdabe7; sha256 15152275eabacec7847748bf6956026f466344dfbcf6d650183d541879ca5370},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41657777. Agents can read the archived copy with the MCP tool read_document.